Insight Molecular Diagnostics

IMDXNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$79.193 M

$2.42 -8.68%

Close of 6 Nov 2026

As of 6 Nov 2026, Insight Molecular Diagnostics (IMDX) has a market capitalization of $79.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.05M

#3302 by revenue

Earnings

-$50.2K

Loss-making

Shares outstanding

32,724,284

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#11Alpha TeknovaTKNO$484.9M
#12ImmucellICCC$89.7M
#13Insight Molecular DiagnosticsIMDX$79.2M
#14BiomericaBMRA$7.40M
#15VolitionrxVNRX$5.84M

What if Insight Molecular Diagnostics were worth as much as…

Open the what-if tool →

Gold $28.2T

$862,872.17

Per share 356,559× higher

Bitcoin $1.53T

$46,688.51

Per share 19,293× higher

Apple $5.02T

$153,274.02

Per share 63,336× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Insight Molecular Diagnostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.